Platform Lead, Translational Research Integration & Support, Singapore
Translational Cancer Consortium
Director, Cancer Discovery Hub, National Cancer Centre Singapore
Consultant, Division of Medical Oncology, National Cancer Centre Singapore
Deputy Director, Division of Medical Oncology Research, National Cancer
Assistant Professor, Duke-NUS Medical School
Dr Jason Chan obtained his medical degree from the National
University of Singapore and achieved his postgraduate accreditation from
the Royal College of Physicians (UK). He completed specialist training
at the National Cancer Centre Singapore and subsequently obtained
a Doctorate from the Cancer Science Institute of Singapore.
His key research interests lie in unravelling the causes and molecular
pathobiology of lymphomas and rare cancers with the aim of improving
clinical care of patients inflicted with these diseases. Dr Chan is Principal
Investigator of the STARLIGHT Initiative for Rare Cancer Research and Education.
Additionally, he is Theme Principal Investigator for SYMPHONY (Singapore
Lymphoma Translational Study) and Executive Committee member for TETRAD
(TargEted TheRApy for blooD Cancer). He has contributed
to major research efforts on Asian-prevalent lymphomas including NK/T-cell
lymphomas and monomorphic epitheliotropic T-cell lymphoma, as
well as breast fibroepithelial tumors, angiosarcomas, and liposarcomas.
For these efforts, he was awarded the Nurturing Clinician Scientist Scheme
by the SingHealth Duke-NUS Academic Medical Centre in 2017, Singapore
National Medical Research Council (NMRC) Research Training Fellowship in
2018 and NMRC Transition Award in 2021. He is also a proud alumnus of
the ESMO Leadership Generation Program in 2022.